View in EDS HTML Full Text PDF Full Text

Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19.

Saved in:
Bibliographic Details
Title: Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19.
Authors: Assaf AR; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, Groton, CT, USA.; Brown University School of Public Health, Providence, RI, USA., Sidhu GS; US Medical Affairs, Pfizer Inc, 537 Alandele Ave, Los Angeles, CA, 90036, USA. gurinder.sidhu@pfizer.com., Soni A; Program in Digital Medicine, University of Massachusetts, North Worcester, MA, USA., Cappelleri JC; Biostatistics, Pfizer Inc, Groton, CT, USA., Draica F; US Medical Affairs, Pfizer Inc, New York, NY, USA., Herbert C; Program in Digital Medicine, University of Massachusetts, North Worcester, MA, USA., Arham I; US Medical Affairs, Pfizer Inc, New York, NY, USA., Bader M; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA., Jimenez C; Global Medical Grants/Institute of Translational Equitable Medicine, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA., Bois M; US Medical Affairs, Pfizer Inc, New York, NY, USA., Silvester E; Strategy Consulting, IQVIA, New York, NY, USA., Meservey J; Strategy Consulting, IQVIA, Boston, MA, USA., Eng V; Strategy Consulting, IQVIA, New York, NY, USA., Nelson M; Strategy Consulting, IQVIA, Boston, MA, USA., Cai Y; Advanced Analytics, IQVIA, Wayne, PA, USA., Nangarlia A; Strategy Consulting, IQVIA, Boston, MA, USA., Tian Z; Advanced Analytics, IQVIA, Wayne, PA, USA., Liu Y; Advanced Analytics, IQVIA, Wayne, PA, USA., Watt S; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA.
Source: Infectious diseases and therapy [Infect Dis Ther] 2024 Jul; Vol. 13 (7), pp. 1683-1701. Date of Electronic Publication: 2024 Jun 13.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38869840
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Assaf+AR%22">Assaf AR</searchLink>; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, Groton, CT, USA.; Brown University School of Public Health, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Sidhu+GS%22">Sidhu GS</searchLink>; US Medical Affairs, Pfizer Inc, 537 Alandele Ave, Los Angeles, CA, 90036, USA. gurinder.sidhu@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Soni+A%22">Soni A</searchLink>; Program in Digital Medicine, University of Massachusetts, North Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cappelleri+JC%22">Cappelleri JC</searchLink>; Biostatistics, Pfizer Inc, Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Draica+F%22">Draica F</searchLink>; US Medical Affairs, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Herbert+C%22">Herbert C</searchLink>; Program in Digital Medicine, University of Massachusetts, North Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Arham+I%22">Arham I</searchLink>; US Medical Affairs, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bader+M%22">Bader M</searchLink>; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jimenez+C%22">Jimenez C</searchLink>; Global Medical Grants/Institute of Translational Equitable Medicine, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bois+M%22">Bois M</searchLink>; US Medical Affairs, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Silvester+E%22">Silvester E</searchLink>; Strategy Consulting, IQVIA, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Meservey+J%22">Meservey J</searchLink>; Strategy Consulting, IQVIA, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Eng+V%22">Eng V</searchLink>; Strategy Consulting, IQVIA, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nelson+M%22">Nelson M</searchLink>; Strategy Consulting, IQVIA, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cai+Y%22">Cai Y</searchLink>; Advanced Analytics, IQVIA, Wayne, PA, USA.<br /><searchLink fieldCode="AU" term="%22Nangarlia+A%22">Nangarlia A</searchLink>; Strategy Consulting, IQVIA, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tian+Z%22">Tian Z</searchLink>; Advanced Analytics, IQVIA, Wayne, PA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Advanced Analytics, IQVIA, Wayne, PA, USA.<br /><searchLink fieldCode="AU" term="%22Watt+S%22">Watt S</searchLink>; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101634499%22">Infectious diseases and therapy</searchLink> [Infect Dis Ther] 2024 Jul; Vol. 13 (7), pp. 1683-1701. <i>Date of Electronic Publication: </i>2024 Jun 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101634499 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8229 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936382%22">21936382 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38869840
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-024-01001-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1683
    Titles:
      – TitleFull: Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Assaf AR
      – PersonEntity:
          Name:
            NameFull: Sidhu GS
      – PersonEntity:
          Name:
            NameFull: Soni A
      – PersonEntity:
          Name:
            NameFull: Cappelleri JC
      – PersonEntity:
          Name:
            NameFull: Draica F
      – PersonEntity:
          Name:
            NameFull: Herbert C
      – PersonEntity:
          Name:
            NameFull: Arham I
      – PersonEntity:
          Name:
            NameFull: Bader M
      – PersonEntity:
          Name:
            NameFull: Jimenez C
      – PersonEntity:
          Name:
            NameFull: Bois M
      – PersonEntity:
          Name:
            NameFull: Silvester E
      – PersonEntity:
          Name:
            NameFull: Meservey J
      – PersonEntity:
          Name:
            NameFull: Eng V
      – PersonEntity:
          Name:
            NameFull: Nelson M
      – PersonEntity:
          Name:
            NameFull: Cai Y
      – PersonEntity:
          Name:
            NameFull: Nangarlia A
      – PersonEntity:
          Name:
            NameFull: Tian Z
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Watt S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2193-8229
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Infectious diseases and therapy
              Type: main
ResultId 1